Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$126.43M
Total Bought:
$39.90M
Total Sold:
$30.70M
Net Transaction:
+$9.20M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Verastem, Inc.(VSTM)2,670,0322,732,079+62,047$23.58M$21.09M16.68%-$2.48M
Adma Biologics Inc739,000740,000+1,000$10.83M$13.50M10.68%+$2.66M
Evolus, Inc.(EOLS)1,536,3911,631,588+95,197$9.43M$10.85M8.58%+$1.42M
Zevra Therapeutics, Inc.(ZVRA)810,000569,088-240,912$7.70M$5.10M4.03%-$2.60M
Inhibikase Therapeutics, Inc.(IKT)735,0192,348,147+1,613,128$1.19M$4.81M3.81%+$3.62M
Abeona Therapeutics Inc.(ABEO)450,970709,505+258,535$2.38M$3.74M2.96%+$1.36M
Nektar Therapeutics(NKTR)85,00085,0000$4.84M$3.59M2.84%-$1.24M
Indivior Plc100,000100,0000$2.41M$3.59M2.84%+$1.18M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0389,916+389,916$0$3.17M2.51%+$3.17M
Kazia Therapeutics LimitedADS(KZIA)0460,359+460,359$0$3.17M2.51%+$3.17M
Xoma Royalty Corporation115,459115,000-459$4.45M$3.06M2.42%-$1.39M
Verrica Pharmaceuticals Inc.(VRCA)0353,669+353,669$0$2.94M2.32%+$2.94M
Cybin D/B/A Helus Pharma(HELP)0339,902+339,902$0$2.78M2.20%+$2.78M
TELA Bio, Inc.(TELA)2,155,5192,352,032+196,513$3.21M$2.78M2.20%-$436.3K
Acadia Pharmaceuticals Inc174,544100,000-74,544$3.72M$2.67M2.11%-$1.05M
Surrozen, Inc.(SRZN)250,146113,631-136,515$3.22M$2.57M2.03%-$655.1K
X4 Pharmaceuticals, Inc.(XFOR)1,056,338593,573-462,765$3.61M$2.37M1.88%-$1.24M
Aytu Biopharma Inc891,855813,704-78,151$1.68M$2.12M1.67%+$438.9K
Day One Biopharmaceuticals I
COM
647,382200,000-447,382$4.56M$1.86M1.47%-$2.70M
Adicet Bio Inc0220,011+220,011$0$1.85M1.47%+$1.85M
Spruce Biosciences Inc019,742+19,742$0$1.72M1.36%+$1.72M
Heron Therapeutics, Inc.(HRTX)850,1001,237,802+387,702$1.07M$1.61M1.27%+$538.0K
Enanta Pharmaceuticals, Inc.(ENTA)305,000100,000-205,000$3.65M$1.58M1.25%-$2.07M
PMV Pharmaceuticals, Inc.(PMVP)1,370,1391,150,759-219,380$1.92M$1.44M1.14%-$479.7K
CAMP4 THERAPEUTICS CORPORATION(CAMP)0228,894+228,894$0$1.40M1.11%+$1.40M
Eledon Pharmaceuticals, Inc.(ELDN)0893,100+893,100$0$1.35M1.07%+$1.35M
Milestone Pharmaceuticals Inc.(MIST)0662,666+662,666$0$1.34M1.06%+$1.34M
OmniAb, Inc.(OABI)2,142,857701,000-1,441,857$3.43M$1.30M1.03%-$2.13M
Quoin Pharmaceuticals, Ltd.ADS(QNRX)078,189+78,189$0$1.13M0.89%+$1.13M
Pulmonx Corporation(LUNG)670,000486,400-183,600$1.09M$1.07M0.85%-$10.5K
Geron Corporation(GERN)1,600,000805,800-794,200$2.19M$1.06M0.84%-$1.13M
Crescent Biopharma, Inc.(CBIO)087,682+87,682$0$1.04M0.82%+$1.04M
Kezar Life Sciences Inc
COM NEW
383,182156,179-227,003$1.49M$982.4K0.78%-$512.0K
Edesa Biotech, Inc.(EDSA)687,500687,5000$1.70M$976.3K0.77%-$721.9K
Boundless Bio, Inc.(BOLD)413,453710,071+296,618$508.5K$852.1K0.67%+$343.5K
Radiopharm Theranostics LimitedADS(RADX)051,000,000+51,000,000$0$850.9K0.67%+$850.9K
Semler Scientific Inc050,000+50,000$0$764.5K0.60%+$764.5K
MaxCyte, Inc.(MXCT)459,018469,018+10,000$725.2K$727.0K0.57%+$1.7K
An2 Therapeutics Inc563,913627,668+63,755$716.2K$715.5K0.57%-$628
Gossamer Bio, Inc.(GOSS)204,770204,7700$538.5K$634.8K0.50%+$96.2K
Zentalis Pharmaceuticals, Inc.(ZNTL)453,800463,700+9,900$685.2K$626.0K0.50%-$59.2K
BioAge Labs, Inc.(BIOA)188,57145,000-143,571$1.11M$595.4K0.47%-$513.4K
MannKind Corporation(MNKD)157,56986,359-71,210$846.1K$489.7K0.39%-$356.5K
Compugen Ltd.(CGEN)0305,400+305,400$0$467.3K0.37%+$467.3K
Codexis, Inc.(CDXS)88,264256,106+167,842$215.4K$417.5K0.33%+$202.1K
In8bio Inc159,421164,893+5,472$345.9K$385.9K0.31%+$39.9K
Fennec Pharmaceuticals Inc.(FENC)050,000+50,000$0$385.0K0.30%+$385.0K
Cabaletta Bio, Inc.(CABA)0171,100+171,100$0$374.7K0.30%+$374.7K
Pasithea Therapeutics Corp.(KTTA)0275,062+275,062$0$354.8K0.28%+$354.8K
Pliant Therapeutics, Inc.(PLRX)289,237230,050-59,187$428.1K$280.7K0.22%-$147.4K
Janux Therapeutics, Inc.(JANX)020,000+20,000$0$276.0K0.22%+$276.0K
Delcath Systems, Inc.(DCTH)027,232+27,232$0$275.0K0.22%+$275.0K
Kiora Pharmaceuticals, Inc.(KPRX)140,598131,144-9,454$390.9K$258.4K0.20%-$132.5K
CNS Pharmaceuticals, Inc.(CNSP)048,827+48,827$0$256.3K0.20%+$256.3K
Tenaya Therapeutics, Inc.(TNYA)0352,001+352,001$0$250.4K0.20%+$250.4K
Ovid Therapeutics Inc.(OVID)0102,367+102,367$0$166.9K0.13%+$166.9K
Tenax Therapeutics, Inc.(TENX)011,884+11,884$0$144.9K0.11%+$144.9K
Evaxion A/SADS(EVAX)020,000+20,000$0$95.4K0.08%+$95.4K
Xilio Therapeutics, Inc.(XLO)0126,270+126,270$0$80.8K0.06%+$80.8K
Curis, Inc.(CRIS)059,349+59,349$0$58.6K0.05%+$58.6K
Processa Pharmaceuticals, Inc.(PCSA)012,323+12,323$0$35.5K0.03%+$35.5K
ABIVAX Société AnonymeADS(ABVX)2,5000-2,500$212.3K$0—-$212.3K
Aclaris Therapeutics, Inc.(ACRS)192,9000-192,900$366.5K$0—-$366.5K
Alumis Inc300,0000-300,000$1.20M$0—-$1.20M
AngioDynamics, Inc.(ANGO)60,0000-60,000$670.2K$0—-$670.2K
Aquestive Therapeutics Inc100,6000-100,600$562.4K$0—-$562.4K
Ardelyx Inc200,0000-200,000$1.10M$0—-$1.10M
Chemomab Therapeutics Ltd.ADS(CMMB)30,0000-30,000$78.9K$0—-$78.9K
CytomX Therapeutics, Inc.(CTMX)125,0000-125,000$398.8K$0—-$398.8K
Dynavax Technologies Corp108,0940-108,094$1.07M$0—-$1.07M
Establishment Labs Holdings Inc.(ESTA)10,5850-10,585$433.9K$0—-$433.9K
Grace Therapeutics, Inc.(GRCE)211,0100-211,010$628.2K$0—-$628.2K
Health Catalyst, Inc.(HCAT)155,5510-155,551$443.3K$0—-$443.3K
Solana CompanyCL A(HSDT)20,0000-20,000$297.8K$0—-$297.8K
Jasper Therapeutics, Inc.(JSPR)20,2000-20,200$48.1K$0—-$48.1K
Larimar Therapeutics, Inc.(LRMR)25,0000-25,000$80.8K$0—-$80.8K
Processa Pharmaceuticals Inc1,030,2000-1,030,200$197.7K$0—-$197.7K
Rezolute, Inc.(RZLT)40,0000-40,000$376.0K$0—-$376.0K
Savara Inc.(SVRA)60,0000-60,000$214.2K$0—-$214.2K
Soleno Therapeutics Inc24,0000-24,000$1.62M$0—-$1.62M
Syndax Pharmaceuticals, Inc.(SNDX)37,2000-37,200$572.3K$0—-$572.3K
Ultragenyx Pharmaceutical Inc.(RARE)20,0000-20,000$601.6K$0—-$601.6K
Vanda Pharmaceuticals Inc.(VNDA)195,0000-195,000$973.0K$0—-$973.0K
Vir Biotechnology, Inc.(VIR)160,0000-160,000$913.6K$0—-$913.6K
Whitehawk Therapeutics, Inc.(WHWK)35,2530-35,253$67.0K$0—-$67.0K
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q4 2025 | TickerTrail